Sai Life Sciences Ltd Quarterly Results

Q4 FY25-26 Results Summary

Revenue

The revenue stands at ₹602.14 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.21 per cent from ₹556.46 crore. This corresponds to a year-on-year *(YoY) growth of 3.91 per cent.

Operating Profit

Operating Profit stands at ₹176.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.68 per cent from ₹179.56 crore. This corresponds to a year-on-year *(YoY) growth of 12.04 per cent.

PBDT

PBDT stands at ₹184.54 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.52 per cent from ₹178.26 crore. This corresponds to a year-on-year *(YoY) growth of 18.08 per cent.

Profit Before Tax

Profit Before Tax stands at ₹139.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.76 per cent from ₹134.18 crore. This corresponds to a year-on-year *(YoY) growth of 17.20 per cent.

Net Profit

Net Profit stands at ₹104.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.85 per cent from ₹100.38 crore. This represents a 18.09 per cent year-on-year *(YoY) growth for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Sai Life Sciences Ltd Earnings

CategoryQ4 FY25-26Q4 FY24-25Change %FY25-26FY24-25Change %
Total Revenue602.14579.513.912,192.491,694.5729.38
Expenses425.59421.930.871,569.331,288.9121.76
Other Income15.819.6064.6949.1336.7833.58
Operating Profit176.55157.5812.04672.29442.4451.95
Depreciation45.3137.4920.86166.86138.5720.42
Interest7.8310.89-28.1039.2476.16-48.48
Profit Before Tax139.23118.8017.20466.19227.70104.74
Tax34.9930.5314.6188.4033.84161.23
Net Profit104.2488.2718.09348.91170.13105.08
CategoryQ4 FY25-26Q3 FY25-26Change %
Total Revenue602.14556.468.21
Expenses425.59376.9012.92
Other Income15.818.3888.66
Operating Profit176.55179.56-1.68
Depreciation45.3144.082.79
Interest7.839.70-19.28
Profit Before Tax139.23134.183.76
Tax34.9933.803.52
Net Profit104.24100.383.85

Sai Life Sciences Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Data Not Found

Sai Life Sciences Ltd Financial Reports

Data not available.

Sai Life Sciences Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 Month3 Months6 Month1 Year
Sai Life0.17%2.17%6.30%21.56%56.74%63.52%
Gland Pharma-0.39%3.16%2.41%37.81%31.99%26.42%
Emcure Pharma2.35%1.67%5.46%9.56%32.96%38.66%
Wockhardt2.79%5.08%0.60%37.50%49.09%24.16%
Piramal Pharma-0.38%2.11%16.59%22.33%26.31%0.54%
Acutaas Chemical-4.13%-7.97%-15.99%15.88%60.14%134.25%
Rubicon Research0.17%-4.46%8.59%52.99%116.92%137.88%

Sai Life Sciences Ltd Corporate Information

Chairman & Exec. Director: Ranga Raju Kanumuri
Managing Director & CEO: Krishnamraju Kanumuri
Independent Non Exe. Director: Ramesh Iyer
Independent Non Exe. Director: Suchita Sharma
Independent Non Exe. Director: Dinesh V Patel
Whole Time Director & CFO: SIVARAMAKRISHNAN CHITTOR
Company Sec. & Compli. Officer: RUNA KUMAR

Sai Life Sciences Ltd News

Jefferies names Sai Life Sciences top CRDMO pick, lists 10 reasons to buy

The brokerage noted that Sai Life remains relatively small compared with its addressable market, with FY25 sales of about $200 million, providing significant room for expansion

Updated On: 12 Mar 2026 | 8:49 AM IST

Sai Life hits record high in weak market; rebounds 5% from day's low

Supported by solid demand, disciplined execution, and capex programs progressing as planned, Sai Life management remains confident in sustaining positive growth momentum.

Updated On: 04 Mar 2026 | 3:04 PM IST

Sai Life soars 25% in 5 weeks, hits record high in weak market; here's why

ICRA expects Sai Life Sciences to maintain strong growth momentum over the medium term on the back of a healthy growth outlook for the industry, good product mix and deepening customer engagement.

Updated On: 27 Feb 2026 | 10:29 AM IST

Sai Life Sciences shares jump 8% as Q3 profit surges 86% YoY

Sai Life Sciences has invested ₹405 crore in capital expenditure so far, against its planned outlay of ₹700 crore for FY26

Updated On: 06 Feb 2026 | 12:38 PM IST
More